MAP - Market Access Podcast
MAP is THE bi-weekly Health Care Market Access Podcast provided by MArS Market Access & Pricing Strategy GmbH
Podcaster
Episoden
Über diesen Podcast
Market Access (or alternatively reimbursement) in health care is
THE key competence in order to be commercially successful with a
new drug, medical device or digital health application. However,
given the fact that market access is a complex field involving
various disciplines and is an ever-changing field, it is difficult
to be up to speed with the different evolvements across the world.
MAP is THE bi-weekly Market Access Podcast provided by MArS Market
Access & Pricing Strategy, which is your health care
consultancy in the German-speaking markets and allows you to keep
up to date with market access , reimbursement and pricing issues in
the D-A-CH countries and around the world. With MAP you will get a
summary of core market access systems and processes as well as
latest changes in regulations including statements and opinions of
core decision makers and stakeholders from various countries. The
CEO and founder of MArS is also the driver behind MAP: Dr. Stefan
Walzer works in the field of payer strategy, pricing, health
economics and reimbursement since 2004 and is the founder and CEO
of MArS Market Access & Pricing Strategy GmbH based in Germany.
MArS makes it as easy as possible for you to get your
Pharmaceutical, MedTech or digital health product to the market and
of course get the price it deserves. Stefan previously worked as a
payer consultant for various global pharmaceutical and medical
device / diagnostic companies, successfully launching their
products across the world. He was the Global Payer Strategy Leader
for various products and compounds at F. Hoffmann – La Roche AG,
where he successfully developed early payer strategies as well as
launching and maintaining the reimbursement process for top brands
and early compounds. Stefan is capable in translating the clinical
and economic evidence into successful reimbursement submissions and
pricing negotiations especially in Austria, Germany and
Switzerland. Additionally he teaches market access, pricing and
negotiations at the State University of Baden-Wuerttemberg and the
University of Applied Sciences Weingarten-Ravensburg (both
Germany). Besides other roles and responsibilities. Stefan was the
head of the committee “Inpatient care” of the German Health
Economic Association (DGGÖ). Furthermore he is also a member of the
Austrian Health Economic Association (ATHEA) and the Swiss Health
Economic Association (SGGÖ). Additionally, he is a member of the
Access Advisory Committee of the Global Pneumonia Prevention
Coalition. Stefan received a Master of Science in Economics from
the University of Tuebingen (Germany), a PhD in Health Economics
from the University of Zurich (Switzerland) and a post-graduate
diploma in Clinical Trials from the London School of Hygiene and
Tropical Medicine (UK). He is co-author of more than 40
peer-reviewed scientific articles and more than 300 scientific
abstracts.
Kommentare (0)